Browse Category

SGX:YZJ News 23 January 2026

Yangzijiang Shipbuilding stock slips again on SGX as Singapore’s STI hits record high

Yangzijiang Shipbuilding stock slips again on SGX as Singapore’s STI hits record high

Singapore, Jan 23, 2026, 15:15 (SGT) — Regular session. Shares of Yangzijiang Shipbuilding (Holdings) Ltd dropped again on Friday, slipping further despite gains in Singapore’s wider market. By 3:10 p.m. local time, the stock had fallen 1.2% to S$3.34. (SG Investors) The Straits Times Index (STI) — Singapore’s main benchmark — hit a record high earlier on Friday, driven by…

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop